Talphera to Participate in Fireside Chat at 2024 Maxim Healthcare Virtual Summit By Investing.com

SAN MATEO, California., October 8, 2024 /PRNewswire/ — Talphera, Inc. (Nasdaq: TLPH), (“Talphera”), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat at the Maxim Virtual Summit Healthcare 2024 and Will be available for 1×1 meetings with registered investors. The summit will be held on October 15-17, 2024.

Event: Maxim Healthcare Virtual Summit 2024

Date: October 16, 2024

Time: 3:00 pm Eastern Time / 12:00 Noon PT

Webcast Link: Maxim Healthcare Virtual Summit 2024

About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera’s lead product candidate, Niyad™, is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the US Food and Drug Administration (FDA).

This release is intended for investors only. For additional information about Talphera, visit www.talphera.com.